The number of people with susceptibility test result for rifampicin in Azerbaijan
Azerbaijan: The number of people with susceptibility test result for rifampicin was 96.11 in 2021. ▬ Flat
Latest (2021)
96.11
Change on year
up 2.8%
World rank
47th
of 146 countries
All-time high
100
in 2019
All-time low
93.54
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Azerbaijan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Azerbaijan recorded 96.11 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 2.8% on the previous year and down 1.5% over five years.
Azerbaijan ranks 47th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Azerbaijan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 97.53 | — |
| 2018 | 99.75 | +2.3% |
| 2019 | 100 | +0.3% |
| 2020 | 93.54 | -6.5% |
| 2021 | 96.11 | +2.8% |
Azerbaijan compared with similar countries
- Azerbaijan's 96.11 is above the median for upper middle income countries, which is 92.7, 1.0× the median. (45 countries reporting)
- Azerbaijan's 96.11 is above the median for Europe & Central Asia, which is 93.52, 1.0× the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 99.09 | 97.53 | 100 | 3 |
| 2020s | 94.83 | 93.54 | 96.11 | 2 |
Countries ranked near Azerbaijan
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,241 deaths per 1,000 people (2090)
- Number of infants who die before age 1 264 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.06 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Azerbaijan?
- The number of people with susceptibility test result for rifampicin in Azerbaijan was 96.11 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Azerbaijan?
- The highest recorded value was 100 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Azerbaijan?
- The lowest recorded value was 93.54 in 2020.
- How does Azerbaijan rank for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 47th out of 146 countries with data for 2021.
- Where does this Azerbaijan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).